Jonathan P. Schneck

Department of Pathology, Johns Hopkins University

Research Area

Biography

Jonathan P. Schneck has not added Biography.
If you are Jonathan P. Schneck and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 3	Year
Publication title Cited by 17	2011
Publication title Cited by 7	2014
Publication title Cited by 5	2018

Other Publications

Article	Year
ImmunoMap: A Bioinformatics Tool for T-cell Repertoire Analysis. Cancer immunology research\| PubMed ID: 29263161	2018
Differential effects of B cell receptor and B cell receptor-FcgammaRIIB1 engagement on docking of Csk to GTPase-activating protein (GAP)-associated p62. The Journal of experimental medicine\| PubMed ID: 9221755	1997
Analysis of the expression of peptide-major histocompatibility complexes using high affinity soluble divalent T cell receptors. The Journal of experimental medicine\| PubMed ID: 9334373	1997
Direct visualization of antigen-specific T cells: HTLV-1 Tax11-19- specific CD8(+) T cells are activated in peripheral blood and accumulate in cerebrospinal fluid from HAM/TSP patients. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 9636190	1998
Lack of coreceptor allows survival of chronically stimulated double-negative alpha/beta T cells: implications for autoimmunity. The Journal of experimental medicine\| PubMed ID: 11369783	2001
Development and use of multimeric major histocompatibility complex molecules. Clinical and diagnostic laboratory immunology\| PubMed ID: 11874855	2002
T cell immunodominance and maintenance of memory regulated by unexpectedly cross-reactive pathogens. Nature immunology\| PubMed ID: 12055626	2002
Probing T cell membrane organization using dimeric MHC-Ig complexes. Journal of immunological methods\| PubMed ID: 12213346	2002
Peptide-beta2-microglobulin-MHC fusion molecules bind antigen-specific T cells and can be used for multivalent MHC-Ig complexes. Journal of immunological methods\| PubMed ID: 12445736	2002
Ex vivo induction and expansion of antigen-specific cytotoxic T cells by HLA-Ig-coated artificial antigen-presenting cells. Nature medicine\| PubMed ID: 12704385	2003
B220+ double-negative T cells suppress polyclonal T cell activation by a Fas-independent mechanism that involves inhibition of IL-2 production. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 12928389	2003
HLA-Ig-based artificial antigen-presenting cells: setting the terms of engagement. Clinical immunology (Orlando, Fla.)\| PubMed ID: 15047202	2004
Quality and quantity: new strategies to improve immunotherapy of cancer. Trends in molecular medicine\| PubMed ID: 15121045	2004
Effect of human papillomavirus-16 infection on CD8+ T-cell recognition of a wild-type sequence p53264-272 peptide in patients with squamous cell carcinoma of the head and neck. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 15501971	2004
Technological advances in adoptive immunotherapy. Drugs of today (Barcelona, Spain : 1998)\| PubMed ID: 15753966	2005
Artificial antigen-presenting cells: artificial solutions for real diseases. Trends in molecular medicine\| PubMed ID: 16103011	2005
Antigen/MHC class II/Ig dimers for study of uveitogenic T cells: IRBP p161-180 presented by both IA and IE molecules. Investigative ophthalmology & visual science\| PubMed ID: 16186361	2005
Evaluation of topoisomerase-1-specific CD8+ T-cell response in systemic sclerosis. Annals of the New York Academy of Sciences\| PubMed ID: 16461796	2005
Gld mutation of Fas ligand increases the frequency and up-regulates cell survival genes in CD25+CD4+ TR cells. International immunology\| PubMed ID: 16769751	2006
Detection of antigen-specific T cells on p/MHC microarrays. Journal of molecular recognition : JMR\| PubMed ID: 17094178	2007
A nanoscopic multivalent antigen-presenting carrier for sensitive detection and drug delivery to T cells. Nanomedicine : nanotechnology, biology, and medicine\| PubMed ID: 17379171	2007
Protection from autoimmune diabetes and T-cell lymphoproliferation induced by FasL mutation are differentially regulated and can be uncoupled pharmacologically. The American journal of pathology\| PubMed ID: 17591957	2007
Killer artificial antigen-presenting cells: a novel strategy to delete specific T cells. Blood\| PubMed ID: 18096763	2008
In vivo functional efficacy of tumor-specific T cells expanded using HLA-Ig based artificial antigen presenting cells (aAPC). Cancer immunology, immunotherapy : CII\| PubMed ID: 18563409	2009
Lectin microarrays identify cell-specific and functionally significant cell surface glycan markers. Glycobiology\| PubMed ID: 18625848	2008
Fas-mediated apoptosis regulates the composition of peripheral alphabeta T cell repertoire by constitutively purging out double negative T cells. PloS one\| PubMed ID: 18941614	2008
Ex vivo induction and expansion of natural killer T cells by CD1d1-Ig coated artificial antigen presenting cells. Journal of immunological methods\| PubMed ID: 19446558	2009
Development of an artificial-antigen-presenting-cell-based assay for the detection of low-frequency virus-specific CD8(+) T cells in whole blood, with application for measles virus. Clinical and vaccine immunology : CVI\| PubMed ID: 19494085	2009
Streptococcus pneumoniae serotype 1 capsular polysaccharide induces CD8CD28 regulatory T lymphocytes by TCR crosslinking. PLoS pathogens\| PubMed ID: 19779562	2009
In vivo administration of artificial antigen-presenting cells activates low-avidity T cells for treatment of cancer. Cancer research\| PubMed ID: 19934317	2009
Overview of a HLA-Ig based "Lego-like system" for T cell monitoring, modulation and expansion. Immunologic research\| PubMed ID: 20087680	2010
Dynamic regulation of functionally distinct virus-specific T cells. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 20133680	2010
Killer artificial antigen-presenting cells: the synthetic embodiment of a 'guided missile'. Immunotherapy\| PubMed ID: 20636007	2010
High-throughput lectin microarray-based analysis of live cell surface glycosylation. Current protocols in protein science / editorial board, John E. Coligan ... [et al.]\| PubMed ID: 21400689	2011
Inhibition of Fas ligand in NOD mice unmasks a protective role for IL-10 against insulitis development. The American journal of pathology\| PubMed ID: 21718680	2011
Decline of influenza-specific CD8+ T cell repertoire in healthy geriatric donors. Immunity & ageing : I & A\| PubMed ID: 21846352	2011
Quantum dot fluorescence characterizes the nanoscale organization of T cell receptors for antigen. Biophysical journal\| PubMed ID: 22261075	2011
Molecular identification of GD3 as a suppressor of the innate immune response in ovarian cancer. Cancer research\| PubMed ID: 22649190	2012
T-cell memory responses elicited by yellow fever vaccine are targeted to overlapping epitopes containing multiple HLA-I and -II binding motifs. PLoS neglected tropical diseases\| PubMed ID: 23383350	2013
Nanoscale artificial antigen presenting cells for T cell immunotherapy. Nanomedicine : nanotechnology, biology, and medicine\| PubMed ID: 23891987	2014
Particle shape dependence of CD8+ T cell activation by artificial antigen presenting cells. Biomaterials\| PubMed ID: 24099710	2014
Sprouty-2 regulates HIV-specific T cell polyfunctionality. The Journal of clinical investigation\| PubMed ID: 24292711	2014
Magnetic field-induced T cell receptor clustering by nanoparticles enhances T cell activation and stimulates antitumor activity. ACS nano\| PubMed ID: 24564881	2014
Linking form to function: Biophysical aspects of artificial antigen presenting cell design. Biochimica et biophysica acta\| PubMed ID: 25200637	2015
Cytotoxic polyfunctionality maturation of cytomegalovirus-pp65-specific CD4 + and CD8 + T-cell responses in older adults positively correlates with response size. Scientific reports\| PubMed ID: 26778409	2016
Dual Targeting Nanoparticle Stimulates the Immune System To Inhibit Tumor Growth. ACS nano\| PubMed ID: 28589725	2017
Biologically Inspired Design of Nanoparticle Artificial Antigen-Presenting Cells for Immunomodulation. Nano letters\| PubMed ID: 28994285	2017
Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab. Cell\| PubMed ID: 29033130	2017
Engineering Platforms for T Cell Modulation. International review of cell and molecular biology\| PubMed ID: 30262034	2018
Efficient magnetic enrichment of antigen-specific T cells by engineering particle properties. Biomaterials\| PubMed ID: 30312851	2018